Top 20 of Psychomotor Agitation

Article title # Publications/# Citations

The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients.

2002: GMBrophy; RKElswick; MSGosnell; MJGrap; KAKeane; PVO'Neal; CNSessler; EPTesoro;


A rating scale for drug-induced akathisia.

1989: TRBarnes;


Effects of abstinence from tobacco: valid symptoms and time course.

2007: JRHughes;


Reconstitution of cell membrane structure in vitro and its transformation into an excitable system.

1962: PMueller; DORudin; HTTien; WCWESCOTT;


Hyperactivity and impaired response habituation in hyperdopaminergic mice.

2001: MGCaron; RRGainetdinov; RHen; SRJones; GWMiller; RSOosting; XZhuang;


Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

2013: American College of Critical Care Medicine; JBarr; DBCoursin; JFDasta; JEDavidson; JWDevlin; EWEly; DKFontaine; ... GLFraser; CGélinas; DLHerr; RJaeschke; AMJoffe; JPKress; BPun; KPuntillo; MARamsay; RRRiker; BRRobinson; CNSessler; YSkrobik; ATung;


Young adult outcome of hyperactive children: adaptive functioning in major life activities.

2006: RABarkley; MFischer; KFletcher; LSmallish;


Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients.

1999: GLFraser; JTPicard; RRRiker;


The neural basis of the psychomotor vigilance task.

2005: LAyalon; ABischoff-Grethe; DFDinges; SPDrummond; SCMednick; MJMeloy;


Clinically defined vascular depression.

1997: GSAlexopoulos; MCharlson; TKakuma; BSMeyers; DSilbersweig; RCYoung;


Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water.

2007: DBellinger; MBouchard; FLaforest; DMergler; LVandelac;


Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.

2010: TNBlatt; PJConn; ELDays; MDGrier; EJHerman; SJadhav; CKJones; ASKane; ... CWLindsley; JEMarlo; UNMenon; CMNiswender; ALRodriguez; JMRook; RLSmith; SRStauffer; PNVinson; CDWeaver; RWilliams; YZhou;


A description of agitation in a nursing home.

1989: JCohen-Mansfield; MSMarx; ASRosenthal;


Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.

1987: JBorenstein; SHFerris; EFranssen; AGeorgotas; BReisberg; SPSalob;


Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects.

1992: EAmico; DCGoff; DCHenderson;


Development of lifetime comorbidity in the World Health Organization world mental health surveys.

2011: SAguilar-Gaxiola; JAlonso; LAndrade; CBenjet; GDe Girolamo; Rde Graaf; KDemyttenaere; JFayyad; ... JGGreen; JMHaro; CyHu; AKaram; RCKessler; SLee; JPLépine; HMatchsinger; KAMcLaughlin; CMihaescu-Pintia; JOrmel; MPetukhova; JPosada-Villa; LJRusso; RSagar; DJStein; TBUstun; AMZaslavsky;


Marijuana abstinence effects in marijuana smokers maintained in their home environment.

2001: AJBudney; JRHughes; BAMoore; PLNovy;


Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.

2007: HEinat; TDGould; HKManji; KCO'Donnell; AMPicchini; RJSchloesser;


Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

2006: Huntington Study Group;


A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.

2007: MAvenarius; JSBailey; RBanan; GCFedere; LGrabowski-Boase; NGrillet; RHice; GDHousley; ... EMKeithley; EALagler; UMüller; HNajmabadi; AFRyan; MSchwander; ASczaniecka; RJSmith; BMSteffy; LMTarantino; TWiltshire;